Hisamitsu Pharmaceutical Co. Company Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan.

The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies.

It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.

The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Hisamitsu Pharmaceutical Co., Inc.

Country	Japan
Founded	1847
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,759
CEO	Kazuhide Nakatomi

Contact Details

Address: Tashirodaikan-machi 408 Tosu, 841-0017 Japan
Phone	81 3 5293 1720
Website	global.hisamitsu

Stock Details

Ticker Symbol	HTSUF
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	March - February
Reporting Currency	JPY
ISIN Number	JP3784600003
SIC Code	2834

Key Executives

Name	Position
Kazuhide Nakatomi	President, Chief Executive Officer and Director
Nobuo Tsutsumi	GM of Legal Dept, Prod Environment, Reliability Assurance and Comp Manager, Executive Off and Dir
Kazunori Ito	Executive Officer and GM of Human Resources Department
Kyu Saito	MD, Executive Officer, GM of Global Business and Director
Shinichi Murayama	Executive Officer of Mgmt. of Internal Audit Division and Domestic Subsidiary Division and Director
Mitsutoshi Tsuruta	Executive Officer and Head of Ethical Division
Masaya Okuno	Executive Officer and Head of Sales and Marketing Division, OTC
Koji Takiyama	Executive Officer, GM of President's Office and Director
Katsuhiko Akiyama	Senior Exe. Officer and GM of MN Commercialization Office